Graves’ Disease: The Most Common Cause of Hyperthyroidism

Graves' Disease — scientific infographic poster

Graves’ disease is an autoimmune disorder in which antibodies called thyroid-stimulating immunoglobulins (TSI), also known as TSH receptor antibodies (TRAb), bind and activate the thyroid-stimulating hormone receptor, driving uncontrolled overproduction of thyroid hormone. It is the most common cause of hyperthyroidism, affecting roughly 0.5 percent of the U.S. population, most commonly women aged 30 to 50. Hallmarks include diffuse goiter, hyperthyroidism, and in roughly a quarter of patients, a distinctive orbital inflammation known as Graves’ ophthalmopathy or thyroid eye disease.

What Graves’ Disease Is
Hyperthyroid Symptoms
Graves’ Ophthalmopathy
Diagnosis
Three Treatment Options
Choosing Between Treatments
Thyroid Storm — A Medical Emergency
Supportive Measures
Connections
Featured Videos

What Graves’ Disease Is

B cells generate TSI antibodies that mimic TSH at the receptor, driving the thyroid to overproduce T4 and T3. Unlike TSH itself, TSI is not subject to pituitary negative-feedback regulation, so hyperthyroidism is continuous rather than pulsed. Triggers include stress, pregnancy, iodine excess, certain infections, and possibly smoking. Graves’ is strongly clustered with other autoimmune disorders (type 1 diabetes, vitiligo, pernicious anemia, celiac).

Hyperthyroid Symptoms

Unintentional weight loss despite increased appetite
Rapid or irregular heartbeat (atrial fibrillation in up to 15%)
Tremor, typically fine and persistent
Heat intolerance, excessive sweating
Anxiety, restlessness, irritability
Insomnia
Muscle weakness, particularly thigh muscles
Frequent bowel movements or diarrhea
Menstrual irregularities, reduced fertility
Hair thinning
Goiter (visible neck swelling)
Bulging eyes, lid retraction, gritty sensation, double vision (in Graves’ ophthalmopathy)
Shortness of breath
Rarely: pretibial myxedema (thickened skin on shins)

Graves’ Ophthalmopathy

Roughly 25–50% of Graves’ patients develop thyroid eye disease, which is a separate autoimmune process affecting orbital tissues. It can occur before, during, or after the onset of hyperthyroidism. Smoking is the strongest modifiable risk factor — smokers are 7- to 8-fold more likely to develop it and have more severe disease. Treatment options include:

Stop smoking immediately. Single most important intervention.
Selenium 200 µg/day for 6 months — improves mild ophthalmopathy in trials.
Teprotumumab (Tepezza) — monoclonal antibody against IGF-1 receptor; dramatic improvement in active disease.
Corticosteroids — intravenous methylprednisolone for moderate-to-severe active disease.
Orbital radiation — occasionally used.
Orbital decompression surgery for severe cases with vision threat.

Diagnosis

Suppressed TSH with elevated free T4 and/or free T3.
TSH receptor antibodies (TRAb) or thyroid-stimulating immunoglobulins (TSI) — positive in >95% of Graves’.
Radioactive iodine uptake (RAIU) — diffusely elevated uptake distinguishes Graves’ from toxic nodular goiter and thyroiditis (where uptake is low).
Thyroid ultrasound with Doppler — diffuse hypervascularity.

Three Treatment Options

Antithyroid drugs (ATDs). Methimazole (preferred) or propylthiouracil block thyroid hormone synthesis. Roughly 50% of patients achieve durable remission after 12–18 months of therapy. Side effects include rash, liver dysfunction, and rare but life-threatening agranulocytosis.
Radioactive iodine (RAI, I-131). Single oral dose ablates thyroid tissue. Highly effective but usually leads to permanent hypothyroidism requiring lifelong levothyroxine. Contraindicated in pregnancy, severe active ophthalmopathy, and unsafe radiation exposure contexts.
Thyroidectomy. Surgical removal of the thyroid. Immediate cure of hyperthyroidism; requires lifelong levothyroxine. Risks include vocal-cord paralysis, hypoparathyroidism, and bleeding.

Choosing Between Treatments

Antithyroid drugs first are preferred in younger patients, small goiters, mild disease, active ophthalmopathy, and pregnancy (PTU in first trimester, methimazole thereafter).
RAI is often preferred in older patients, larger goiters, and those failing ATD therapy — but not in active thyroid eye disease.
Surgery is preferred for large goiters causing compressive symptoms, coexisting suspicious nodules, severe active ophthalmopathy, and pregnancy unresponsive to ATDs.

During active hyperthyroidism — before definitive treatment takes effect — beta-blockers (typically propranolol) are used to control tachycardia, tremor, and anxiety.

Thyroid Storm — A Medical Emergency

Thyroid storm is severe decompensated hyperthyroidism with fever, severe tachycardia, heart failure, altered mental status, and GI symptoms. Mortality is 10–30% even with treatment. Triggers include infection, surgery, trauma, childbirth, and medication nonadherence. Treatment is a coordinated emergency protocol of high-dose ATDs, beta-blockers, iodine (after ATDs), corticosteroids, and supportive care.

Supportive Measures

Stop smoking absolutely.
Adequate caloric intake; weight loss is usually already excessive.
Selenium 200 µg/day — benefits ophthalmopathy and may reduce antibody titers.
Avoid iodine excess (kelp, iodine-rich supplements).
Manage stress — a common trigger for flares.
Bone-health support; hyperthyroidism drives bone resorption.

Connections

↑ Back to Table of Contents

Research Papers

The following PubMed topic searches aggregate the current peer-reviewed literature. Each link opens a live PubMed query — results update as new studies are indexed.